Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2011 1
2013 1
2014 1
2017 1
2018 1
2020 3
2021 2
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Chronic antigen in solid tumors drives a distinct program of T cell residence.
Gavil NV, Scott MC, Weyu E, Smith OC, O'Flanagan SD, Wijeyesinghe S, Lotfi-Emran S, Shiao SL, Vezys V, Masopust D. Gavil NV, et al. Among authors: lotfi emran s. Sci Immunol. 2023 Jun 8;8(84):eadd5976. doi: 10.1126/sciimmunol.add5976. Epub 2023 Jun 2. Sci Immunol. 2023. PMID: 37267383 Free PMC article.
Immunomodulation in COVID-19.
Ingraham NE, Lotfi-Emran S, Thielen BK, Techar K, Morris RS, Holtan SG, Dudley RA, Tignanelli CJ. Ingraham NE, et al. Among authors: lotfi emran s. Lancet Respir Med. 2020 Jun;8(6):544-546. doi: 10.1016/S2213-2600(20)30226-5. Epub 2020 May 4. Lancet Respir Med. 2020. PMID: 32380023 Free PMC article. No abstract available.
Tissue-resident memory T cells trigger rapid exudation and local antibody accumulation.
Rosato PC, Lotfi-Emran S, Joag V, Wijeyesinghe S, Quarnstrom CF, Degefu HN, Nedellec R, Schenkel JM, Beura LK, Hangartner L, Burton DR, Masopust D. Rosato PC, et al. Among authors: lotfi emran s. Mucosal Immunol. 2023 Feb;16(1):17-26. doi: 10.1016/j.mucimm.2022.11.004. Epub 2023 Jan 16. Mucosal Immunol. 2023. PMID: 36657662 Free PMC article.
mTOR inhibition in COVID-19: A commentary and review of efficacy in RNA viruses.
Karam BS, Morris RS, Bramante CT, Puskarich M, Zolfaghari EJ, Lotfi-Emran S, Ingraham NE, Charles A, Odde DJ, Tignanelli CJ. Karam BS, et al. Among authors: lotfi emran s. J Med Virol. 2021 Apr;93(4):1843-1846. doi: 10.1002/jmv.26728. Epub 2020 Dec 17. J Med Virol. 2021. PMID: 33314219 Free PMC article. Review.
Cryoglobulin-Associated Retinal Vasculitis: Retrospective Case Series.
Thomas C, Zubair T, Monteagudo L, Lotfi-Emran S, Yamanuha J. Thomas C, et al. Among authors: lotfi emran s. J Vitreoretin Dis. 2023 Oct 9;8(2):181-185. doi: 10.1177/24741264231203788. eCollection 2024 Mar-Apr. J Vitreoretin Dis. 2023. PMID: 38465357
Characterizing COVID-19 clinical phenotypes and associated comorbidities and complication profiles.
Lusczek ER, Ingraham NE, Karam BS, Proper J, Siegel L, Helgeson ES, Lotfi-Emran S, Zolfaghari EJ, Jones E, Usher MG, Chipman JG, Dudley RA, Benson B, Melton GB, Charles A, Lupei MI, Tignanelli CJ. Lusczek ER, et al. Among authors: lotfi emran s. PLoS One. 2021 Mar 31;16(3):e0248956. doi: 10.1371/journal.pone.0248956. eCollection 2021. PLoS One. 2021. PMID: 33788884 Free PMC article.
Human mast cells present antigen to autologous CD4+ T cells.
Lotfi-Emran S, Ward BR, Le QT, Pozez AL, Manjili MH, Woodfolk JA, Schwartz LB. Lotfi-Emran S, et al. J Allergy Clin Immunol. 2018 Jan;141(1):311-321.e10. doi: 10.1016/j.jaci.2017.02.048. Epub 2017 Jun 15. J Allergy Clin Immunol. 2018. PMID: 28624612
Characterizing COVID-19 Clinical Phenotypes and Associated Comorbidities and Complication Profiles.
Lusczek ER, Ingraham NE, Karam B, Proper J, Siegel L, Helgeson E, Lotfi-Emran S, Zolfaghari EJ, Jones E, Usher M, Chipman J, Dudley RA, Benson B, Melton GB, Charles A, Lupei MI, Tignanelli CJ. Lusczek ER, et al. Among authors: lotfi emran s. medRxiv [Preprint]. 2020 Sep 14:2020.09.12.20193391. doi: 10.1101/2020.09.12.20193391. medRxiv. 2020. PMID: 32995813 Free PMC article. Updated. Preprint.
Development of a proteomic signature associated with severe disease for patients with COVID-19 using data from 5 multicenter, randomized, controlled, and prospective studies.
Castro-Pearson S, Samorodnitsky S, Yang K, Lotfi-Emran S, Ingraham NE, Bramante C, Jones EK, Greising S, Yu M, Steffen B, Svensson J, Åhlberg E, Österberg B, Wacker D, Guan W, Puskarich M, Smed-Sörensen A, Lusczek E, Safo SE, Tignanelli CJ. Castro-Pearson S, et al. Among authors: lotfi emran s. Sci Rep. 2023 Nov 20;13(1):20315. doi: 10.1038/s41598-023-46343-1. Sci Rep. 2023. PMID: 37985892 Free PMC article.
16 results